MupiroNasal 20 mgg nasal ointment

MupiroNasal 20 mg/g nasal ointment nasal, manufactured by Balkanpharma-Razgrad AD, is a medicinal product containing the active substance mupirocin, as mupirocin calcium, intended for use in the nose.
Mupirocin is an antibacterial agent for topical use and a medicinal agent of choice for elimination of Staphylococci, incl. methicillin-resistant strains of S. aureus (MRSA) in the nose.
Mupirocin is active against most microorganisms, causing skin bacterial infections – furuncles, impetigo, open wounds and others.
Mupirocin is suitable for preoperative elimination of nasal carriage of S. aureus in patients in intensive care units, patients undergoing cardio-thoracic surgical intervention, patients of abdominal surgery, patients undergoing orthopaedic surgical intervention, e.g. joint arthroplasty, patients of neurosurgery, patients of eye surgery, patients undergoing haemodialysis and peritoneal dialysis, for reducing S. aureus colonisation in HIV-positive patients.
As a result of its specific mode of action and unique chemical structure, mupirocin shows no cross-resistance with other antibiotics, and the risk for development of resistant bacteria is low, when using the product in accordance with its therapeutic indications.

Subgroup:
Decongestants and other nasal preparations for topical use

Medical product subject to medical prescription

Route (s) of administration: Nasal use

Nature and contents of container: MupiroNasal 20 mg/g ointment of 3 g in an aluminium tube fitted with a cannula and closed with a screw cap.
One tube with a patient leaflet is inserted in a cardboard carton.

Prescriptions:
MupiroNasal is a local antibiotic that is used to treat bacterial infections of the nose. It is also used to remove nasal carriage of certain types of bacteria (the so-called Staphylococci), which commonly cause infections in haemodialysis patients.